Results 121 to 130 of about 124,514 (155)

A serologic response in human infection with Enterobacteriaceae

The American Journal of the Medical Sciences, 1977
Sera from patients infected with Escherichia coli, Proteus, Klebsiella, and Serratia were studied for precipitins to ultrasonic extracts of these organisms in gel-diffusion plates. Sera from 66 per cent of these patients contained precipitins when initially tested. Twenty-four per cent of sera tested in the first week after onset of infection contained
J C, Crowder, J P, Rissing, J W, Smith, A, White   +3 more
openaire   +2 more sources

Risk of resistant infections with Enterobacteriaceae in hospitalized neonates

The Pediatric Infectious Disease Journal, 2002
To determine the risk factors associated with progression from colonization to infection with health care-associated antimicrobial-nonsusceptible Enterobacteriaceae (ANE) in critically ill neonates.During a 3-year period (1998 to 2000), surveillance rectal cultures were performed on neonates admitted to our Level III neonatal intensive care unit after ...
Nalini, Singh, Kantilal M, Patel, Marie-Michèle, Léger, Billie, Short, Bruce M, Sprague, Nnenna, Kalu, Joseph M, Campos   +6 more
openaire   +2 more sources

Treatment of infections caused by carbapenemase-producing Enterobacteriaceae

Enfermedades Infecciosas y Microbiología Clínica, 2014
Treatment of infections caused by carbapenemase-producing Enterobacteriaceae (CPE) is currently one of the most important challenges of infectious diseases. The available information is based on in vitro studies, some animal model data and a few case studies and retrospective cohorts; appropriate data are lacking or are very scarce for some old ...
Jesús, Rodríguez-Baño, José Miguel, Cisneros, Carlota, Gudiol, José Antonio, Martínez   +3 more
openaire   +2 more sources

Optimizing therapy in carbapenem-resistant Enterobacteriaceae infections

Current Opinion in Infectious Diseases, 2018
Purpose of review In the absence of randomized clinical trial data, questions remain regarding the optimal treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections. CRE have historically been susceptible to polymyxins, tigecycline or
Tumbarello M., Losito A. R., Giamarellou H.   +2 more
openaire   +2 more sources

Use of meropenem in treating carbapenem-resistant Enterobacteriaceae infections

Expert Review of Anti-infective Therapy, 2019
Introduction: The epidemiology of carbapenem-resistant Enterobacterales (CRE) is increasingly worldwide. Production of carbapenemases is the most common and efficient mechanism of carbapenem resistance, and could theoretically be overcome by optimizing the pharmacokinetic/pharmacodynamic (PK/PD) behavior of meropenem.
Pascale R., Giannella M., Bartoletti M., Viale P., Pea F.   +4 more
openaire   +3 more sources

ESBL-producing Enterobacteriaceae: controlling the spread of infection

British Journal of Nursing, 2007
Extended spectrum ß-lactamase (ESBL)-producing Enterobacteriaceae were first reported in Europe in the 1980s and have since become a worldwide problem. This has resulted in increased morbidity, mortality and cost in treating the infections they cause (Paterson et al, 2001; Bisson et al, 2002). In the UK the prevalence of ESBL rose from 5.4% in 1997 to
openaire   +2 more sources

Disparity in infection control practices for multidrug-resistant Enterobacteriaceae

American Journal of Infection Control, 2012
There is a lack of empiric evidence regarding the optimal approach to controlling the transmission of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) and carbapenem-resistant Enterobacteriaceae (CRE). In this context, we expect that infection control practices for these organisms vary widely between hospitals.A survey examining ...
Christopher, Lowe, Kevin, Katz, Allison, McGeer, Matthew P, Muller   +3 more
openaire   +2 more sources

The Role of Vaginal Colonization with Enterobacteriaceae in Recurrent Urinary Infections

Journal of Urology, 1975
Quantitative cultures of the vaginal introitus for Enterobacteriaceae, S. faecalis and P. aeruginosa were compared in 20 premenopausal normal women (200 cultures) to 198 consecutive cultures from 9 premenopausal women in between episodes of bacteriuria. Introital colonization in patients susceptible to urinary infections was significantly higher for E.
T A, Stamey, C C, Sexton
openaire   +2 more sources

Ceftazidime therapy of infections caused by Enterobacteriaceae and Pseudomonas aeruginosa

Journal of Antimicrobial Chemotherapy, 1983
Sixteen patients with serious Gram-negative bacillary infections were treated with intravenous ceftazidime, 2 g every 8 h. The majority of patients had bacteraemia or pneumonitis or both. Ten patients were cured and six improved. Seven of ten patients infected with Pseudomonas aeruginosa were cured, and three improved.
M J, Maslow, A, Rosenberg, A A, Pollock, R A, Press, D, Silverman, W, El-Sadr, A S, Richmond, M S, Simberkoff, J J, Rahal   +8 more
openaire   +2 more sources

Enterobacteriaceae populations during experimental Salmonella infection in pigs

Veterinary Microbiology, 2010
Salmonella infection might affect other intestinal Enterobacteriaceae populations and possible correlations between single Enterobacteriaceae populations would help to predict subclinical Salmonella infections in pigs. In one experimental setup, weaned piglets (n=40) were infected with Salmonella and sacrificed at 3h, 24h, 72 h or 28 days post ...
Sebastian, Guenther, Matthias, Filter, Karsten, Tedin, Istvan, Szabo, Lothar H, Wieler, Karsten, Nöckler, Nicole, Walk, Peter, Schierack   +7 more
openaire   +2 more sources